Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02381522 · ClinicalTrials.gov registry record · NA
Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02381522 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 26 participants.
The verdict
NCT02381522, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate if briefly stopping blood flow to the patient's leg will lead to the patient's body being better able to tolerate possible decreased blood flow to regions of the brain which otherwise frequently happens after subarachnoid hemorrhage. Previous studies show that various organs such as the heart, brain or kidney can tolerate longer periods of decreased blood flow if prior to that insult shorter periods of decreased blood flow were experienced.
Interventions
- OTHER Remote Ischemic Pre-conditioning
- OTHER Sham RIPC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-03-01 |
| Est. Completion | 2017-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02381522
The ClinicalTrials.gov registry entry for NCT02381522 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Remote Ischemic Pre-conditioning is the first listed.
NCT02381522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02381522 about?
NCT02381522 is a clinical study titled "Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage". The purpose of the study is to investigate if briefly stopping blood flow to the patient's leg will lead to the patient's body being better able to tolerate possible decreased blood flow to regions of the brain which otherwise frequently happens after subarachnoid hemorrhage. Previous studies show ...
What is the current status of trial NCT02381522?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2015-03-01. Estimated completion is 2017-12-20.
What interventions are being tested in trial NCT02381522?
The interventions under investigation include: Remote Ischemic Pre-conditioning (OTHER), Sham RIPC (OTHER).
Who is sponsoring clinical trial NCT02381522?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.